Preeclampsia Treatment Boston MA

Researchers already knew that changes in the concentrations of two proteins—placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFit1)—keyed the onset of milder forms of preeclampsia but did not seem to cause the life'threatening levels of high blood pressure seen in severe cases.

Kara A Pitt, MD
(508) 941-6444
650 Centre St
Brockton, MA
Business
Womens Health Affiliates
Specialties
Obstetrics & Gynecology

Data Provided by:
Sonia Ranganath
(617) 636-5000
750 Washington St
Boston, MA
Specialty
Obstetrics & Gynecology

Data Provided by:
Balmookoot Balgobin
(617) 414-2000
850 Harrison Ave
Boston, MA
Specialty
Obstetrics & Gynecology

Data Provided by:
Mohamed Adel Hamid
(617) 414-2000
850 Harrison Ave
Boston, MA
Specialty
Obstetrics & Gynecology

Data Provided by:
Lori R Berkowitz
(617) 726-7635
55 Fruit Street Yaw 4
Boston, MA
Specialty
Obstetrics & Gynecology

Data Provided by:
Danielle M Roncari
(617) 636-0265
750 Washington St
Boston, MA
Specialty
Obstetrics & Gynecology

Data Provided by:
Ramey Drew Littell, MD
125 Nashua St
Boston, MA
Specialties
Obstetrics & Gynecology
Gender
Male
Education
Medical School: Univ Of Fl Coll Of Med, Gainesville Fl 32610
Graduation Year: 1996

Data Provided by:
Curtis L Cetrulo
(617) 636-5000
750 Washington St
Boston, MA
Specialty
Obstetrics & Gynecology

Data Provided by:
Jan Leslie Shifren
(617) 726-8868
55 Fruit Street Yaw 10
Boston, MA
Specialty
Obstetrics & Gynecology, Reproductive Endocrinology

Data Provided by:
Nancy Anne Callan, MD
850 Harrison Ave # ACC4
Boston, MA
Specialties
Obstetrics & Gynecology
Gender
Female
Education
Medical School: Univ Of Mi Med Sch, Ann Arbor Mi 48109
Graduation Year: 1976

Data Provided by:
Data Provided by:

Early Warning Signs of Preeclampsia

Provided by: 

By Kathryn Ayers

High blood pressure, fluid retention, and excess protein in the urine all signal the onset of preeclampsia, a condition that affects one in 20 women during the third trimester of pregnancy. While a cause for concern in all cases—about 200,000 women suffer from preeclampsia in the US each year, and it is a leading cause of premature births—only those women who experience large and sudden increases in blood pressure face the threat of severe complications for themselves and their fetuses.

Researchers already knew that changes in the concentrations of two proteins—placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFit1)—keyed the onset of milder forms of preeclampsia but did not seem to cause the life-threatening levels of high blood pressure seen in severe cases. Their new study in The New England Journal of Medicine names a third factor, soluble endoglin, that seems to kick preeclampsia into overdrive. This protein, which the researchers found in high concentrations in the placentas of women with severe preeclampsia, normally helps maintain the blood vessels, but when it sloughs off the blood vessel walls and combines with sFit1, it actually weakens them.

The study reports that soluble endoglin levels begin to increase markedly two to three months before the onset of preeclampsia and that this increase is usually accompanied by an increased ratio of sFit1 to PlGF. This forewarning should enable researchers to develop a diagnostic test that will allow healthcare providers to counter a major cause of maternal and fetal mortality worldwide.

Author: Kathryn Ayers

Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...

Click here to read more from Natural Solutions